In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, CryoPort Inc (NASDAQ: CYRX) closed at $6.74 down -5.87% from its previous closing price of $7.16. In other words, the price has decreased by -$5.87 from its previous closing price. On the day, 0.65 million shares were traded. CYRX stock price reached its highest trading level at $7.22 during the session, while it also had its lowest trading level at $6.69.
Ratios:
For a deeper understanding of CryoPort Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.24 and its Current Ratio is at 5.56. In the meantime, Its Debt-to-Equity ratio is 0.61 whereas as Long-Term Debt/Eq ratio is at 0.56.
On March 24, 2025, UBS Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $10.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $11.Guggenheim initiated its Buy rating on December 19, 2024, with a $11 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 22 ’25 when Mandalam Ramkumar sold 40,728 shares for $7.24 per share. The transaction valued at 294,899 led to the insider holds 92,328 shares of the business.
RAMKUMAR MANDALAM bought 40,728 shares of CYRX for $273,285 on Jul 22 ’25. On Jun 24 ’25, another insider, SHELTON JERRELL, who serves as the President, CEO of the company, sold 16,344 shares for $7.06 each. As a result, the insider received 115,366 and left with 912,419 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CYRX now has a Market Capitalization of 337924704 and an Enterprise Value of 372836864. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.57 while its Price-to-Book (P/B) ratio in mrq is 0.93. Its current Enterprise Value per Revenue stands at 1.606 whereas that against EBITDA is -11.425.
Stock Price History:
The Beta on a monthly basis for CYRX is 1.61, which has changed by -0.13256115 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, CYRX has reached a high of $9.66, while it has fallen to a 52-week low of $4.58. The 50-Day Moving Average of the stock is -3.99%, while the 200-Day Moving Average is calculated to be -2.36%.
Shares Statistics:
For the past three months, CYRX has traded an average of 491.37K shares per day and 514290 over the past ten days. A total of 50.14M shares are outstanding, with a floating share count of 47.92M. Insiders hold about 4.43% of the company’s shares, while institutions hold 92.24% stake in the company. Shares short for CYRX as of 1752537600 were 2697153 with a Short Ratio of 5.49, compared to 1749772800 on 2437721. Therefore, it implies a Short% of Shares Outstanding of 2697153 and a Short% of Float of 6.41.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
